Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Bank Pictet & Cie Europe AG

Bank Pictet & Cie Europe AG trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.2% during the third quarter, Holdings Channel.com reports. The firm owned 190,086 shares of the medical equipment provider’s stock after selling 6,347 shares during the period. Intuitive Surgical accounts for about 2.2% of Bank Pictet & Cie Europe AG’s holdings, making the stock its 11th largest holding. Bank Pictet & Cie Europe AG’s holdings in Intuitive Surgical were worth $93,384,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. Ullmann Wealth Partners Group LLC lifted its position in shares of Intuitive Surgical by 1.6% in the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after buying an additional 21 shares during the last quarter. One Wealth Management Investment & Advisory Services LLC raised its stake in Intuitive Surgical by 3.4% during the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after acquiring an additional 23 shares during the period. Daymark Wealth Partners LLC lifted its holdings in Intuitive Surgical by 0.3% in the third quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock worth $3,452,000 after acquiring an additional 24 shares during the last quarter. Indiana Trust & Investment Management CO boosted its stake in Intuitive Surgical by 5.3% in the second quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after acquiring an additional 25 shares during the period. Finally, Hoxton Planning & Management LLC grew its holdings in shares of Intuitive Surgical by 4.9% during the second quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock valued at $238,000 after purchasing an additional 25 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 1,413 shares of the company’s stock in a transaction on Friday, July 26th. The stock was sold at an average price of $438.60, for a total transaction of $619,741.80. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,414,931.60. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other Intuitive Surgical news, insider Mark Brosius sold 2,115 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the transaction, the insider now directly owns 295 shares in the company, valued at approximately $145,113.45. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 1,413 shares of the business’s stock in a transaction on Friday, July 26th. The shares were sold at an average price of $438.60, for a total transaction of $619,741.80. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,414,931.60. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 51,455 shares of company stock worth $24,911,155 in the last three months. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $517.50 on Wednesday. The firm has a market cap of $183.56 billion, a price-to-earnings ratio of 93.41, a price-to-earnings-growth ratio of 5.40 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $523.34. The firm’s 50 day moving average price is $485.88 and its two-hundred day moving average price is $440.46.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Citigroup upped their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research note on Friday, October 18th. Piper Sandler restated an “overweight” rating and issued a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, BTIG Research set a $535.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.